Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nitric oxide as a target in stroke therapy

Feb. 6, 1998

Migranal Nasal Spray now available in U.S.

Feb. 6, 1998

NIF is neuroprotective in rat model of ischemia

Feb. 5, 1998

Algos initiates FDA approval process for MorphiDex

Feb. 5, 1998

Preclinical pharmacology of ebselen described in depth

Feb. 5, 1998

Novel PTK-related technology from Genentech and collaborators

Feb. 5, 1998

Potent SK(Ca) channel blocker prepared by European university researchers

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

Neuroprotective activity described for CoCensys neurosteroid

Feb. 4, 1998

Neuroprotective effects of IL-1ra

Feb. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...